The growing and ongoing obsession for treating obesity has led to the use of diabetic treatment injections to try and cure this disease. Anti-diabetic drugs (e.g., Liraglutide/Saxenda, Ozempic, Metformin and Mounjaro) have shown promising weight-loss results in clinical settings. Our study analyzes the discontinuation and non-publication of clinical trials concerning the use of diabetes injections (GLP-1 Agonists) in treating obesity.
(2025). From Hope to Silence: The Hidden Stories of 128,127 Patients in Discontinued and Unpublished Obesity Trials. Egyptian Society of Diabetes and Lipidology Journal, 5(2), -. doi: 10.21608/esdlj.2025.456296
MLA
. "From Hope to Silence: The Hidden Stories of 128,127 Patients in Discontinued and Unpublished Obesity Trials", Egyptian Society of Diabetes and Lipidology Journal, 5, 2, 2025, -. doi: 10.21608/esdlj.2025.456296
HARVARD
(2025). 'From Hope to Silence: The Hidden Stories of 128,127 Patients in Discontinued and Unpublished Obesity Trials', Egyptian Society of Diabetes and Lipidology Journal, 5(2), pp. -. doi: 10.21608/esdlj.2025.456296
VANCOUVER
From Hope to Silence: The Hidden Stories of 128,127 Patients in Discontinued and Unpublished Obesity Trials. Egyptian Society of Diabetes and Lipidology Journal, 2025; 5(2): -. doi: 10.21608/esdlj.2025.456296
)
